Steven Clausnitzer

I'm on the phone with 20 and 15.

So I'm on the phone with, um, you know, my very good friend, um, and business partner previous to this, Dr. Mark Katakowski and Mark spent his entire career working with these cells.

He knows them better than just about anyone in the world.

They're old friends to him.

Um, so we're on the phone.

We're actually working on a cryptocurrency company at the time, um, called coin coin amp, uh, that was in the Bitcoin space.

And this is before it was cool to do this, by the way.

But we were working on that.

And Mark started telling me a story about how he had applied to the NIH and the NIA for a grant to take cells from young mice, put them in genetically matched older mice, because he was sure that the mice would live longer based on his work.

Did they?

Well, check it out.

He got denied that grant, both those grants.

But he had found out on that phone call, he was telling me that two other groups had since done that same work.

and had shown that the mice lived about 16% to 20% longer with just one reintroduction.

That's a really good question.

So these are syngenic mice, so they might as well be genetically matched, right?

Yes, exactly.

So Mark's telling me this, and he's like, I'm not mad that I didn't get the grant or that someone else perhaps is getting credit for...

you know, hypothesis I had before they did.

I'm mad because I'm turning 40 years old and I can't find anyone that will store my stem cells.